Vanita R Aroda

53PUBLICATIONS

123CO-AUTHORS

PharmacogenomicsTraditional Chinese medicine and treatmentsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Cross-sectional analysis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (53)

Sort by Publication Date:

|Jun 13, 2026

Evidence-informed guidance for the clinical use of oral semaglutide in obesity management.

|Apr 17, 2026

Semaglutide Treatment in Young Adults Living With Type 2 Diabetes: A Post Hoc Analysis From the SUSTAIN and PIONEER Clinical Trials.

|Nov 25, 2025

Assessment of thyroid cancer risk associated with glucagon-like peptide 1 receptor agonist use.

Tina Vilsbøll, Michael Stellfeld, Vanita R Aroda

|Jun 23, 2025

Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment.

Ralph A DeFronzo, Vivian Fonseca, Vanita R Aroda

|May 27, 2025

Overweight and Obesity - Capturing the Whole Picture.

Vanita R Aroda, Leigh Perreault

|May 22, 2025

Time to Treatment Intensification with Glucagon-Like Peptide-1 Receptor Agonists Versus Comparators in People with Type 2 Diabetes Treated with Metformin.

John W Ostrominski, Vanita R Aroda, Uffe C Braae

Pageof 9

Frequent Collaborators

10 joint publications

Julio Rosenstock

John B Buse

Kamlesh Khunti

Lawrence Blonde

Stefano Del Prato

Juan Pablo Frias

Steven E Kahn

Ildiko Lingvay

Melanie J Davies

Martin Haluzík

Frequent Collaborators

10 joint publications

Julio Rosenstock

8 joint publications

John B Buse

6 joint publications

Kamlesh Khunti

6 joint publications

Lawrence Blonde